Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,417.72
-12.5945-0.52%
Number of Gainers:33
Number of Losers:63
Number of Flat:1
PE:- -
High:2,433.10
Open:2,430.65
Low:2,413.28
Close:2,430.32
Volume:1.22B
Turnover:258.39B
Market Cap:50.69T
Float Cap:47.38T

Loading ...

US Stocks-Wall St Futures Slip as Oil Surge Puts Markets on Edge

Reuters
·
Sep 08

Amazon Enlists Banks to Arrange Inaugural Sterling Bond Offering with Tenors Ranging From Three to Nineteen Years

Deep News
·
Sep 08

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

TIPRANKS
·
Sep 08

ServiceNow price target raised to $170 from $150 at BTIG

TIPRANKS
·
Sep 08

Regenxbio to Join Baird, Morgan Stanley Healthcare Investor Conferences

Reuters
·
Sep 08

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 08

Intel : Northland Capital Raises to Outperform from Market Perform Rating

THOMSON REUTERS
·
Sep 08

Set - 16 New DRS Referencing Securities Listed on Nasdaq, NYSE and Euronext Paris Shares Include Palantir, Intel, Airbus

THOMSON REUTERS
·
Sep 08

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Reuters
·
Sep 08

Beamr Partners with VAST Data to Develop AI Video Archive Workflows with Nvidia Tech

Reuters
·
Sep 08

Nearly Four Years Into Nvidia H100 Mass Production, Ornn Data Shows Rental Prices Jump 22% in a Month as Huang Emphasizes GPU Revenue Capability

TradingKey
·
Sep 08

BETA Technologies to Join Jefferies Global Industrials Conference Fireside Chat

Reuters
·
Sep 08

Erasca to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 08

Beamr and Vast Data Partner to AI-Enhance and Monetize Video Archives with Nvidia

THOMSON REUTERS
·
Sep 08

Exclusive-Google Rolls Out Search Results Changes in Europe to Avoid Fresh EU Antitrust Fines

THOMSON REUTERS
·
Sep 08

Exclusive-Changes Give Specialised Search Engines More Prominence in Search Results, Google Says

THOMSON REUTERS
·
Sep 08

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS
·
Sep 08

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS
·
Sep 08

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Dow Jones
·
Sep 08

Odds ‘4 to 1’ against Apple as Ternus takes helm, says Needham

TIPRANKS
·
Sep 08